Effects of eribulin, vincristine, paclitaxel and ixabepilone on fast axonal transport and kinesin-1 driven microtubule gliding: implications for chemotherapy-induced peripheral neuropathy.
about
Eribulin in Cancer TreatmentMechanisms involved in the development of chemotherapy-induced neuropathyChemotherapy-induced peripheral neurotoxicity: a critical analysisModeling chemotherapeutic neurotoxicity with human induced pluripotent stem cell-derived neuronal cellsTau Biology and Tau-Directed Therapies for Alzheimer's DiseaseEribulin for the treatment of metastatic breast cancer: an update on its safety and efficacyAβ-mediated spine changes in the hippocampus are microtubule-dependent and can be reversed by a subnanomolar concentration of the microtubule-stabilizing agent epothilone DEpothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.Integrated systems pharmacology analysis of clinical drug-induced peripheral neuropathy.Microtubules and their role in cellular stress in cancerMolecular imaging detects impairment in the retrograde axonal transport mechanism after radiation-induced spinal cord injury.Anterograde transport blockade precedes deficits in retrograde transport in the visual projection of the DBA/2J mouse model of glaucoma.Repurposing FDA-approved drugs as therapeutics to treat Rift Valley fever virus infection.Pharmacoethnicity in Paclitaxel-Induced Sensory Peripheral NeuropathyNew Insights into Potential Prevention and Management Options for Chemotherapy-Induced Peripheral Neuropathy.Eribulin mesylate: mechanism of action of a unique microtubule-targeting agent.Nerve growth factor alters microtubule targeting agent-induced neurotransmitter release but not MTA-induced neurite retraction in sensory neurons.Sustained Accumulation of Microtubule-Binding Chemotherapy Drugs in the Peripheral Nervous System: Correlations with Time Course and Neurotoxic Severity.Axonal trafficking of NMNAT2 and its roles in axon growth and survival in vivo.Limb Hypothermia for Preventing Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer Patients: A Pilot StudyChemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literature.Long-Term Effects, Pathophysiological Mechanisms, and Risk Factors of Chemotherapy-Induced Peripheral Neuropathies: A Comprehensive Literature Review.Interphase microtubules: chief casualties in the war on cancer?Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain.Native kinesin-1 does not bind preferentially to GTP-tubulin-rich microtubules in vitro.Eribulin in advanced liposarcoma and leiomyosarcoma.Targeting Glycoprotein NMB With Antibody-Drug Conjugate, Glembatumumab Vedotin, for the Treatment of Osteosarcoma.Chemotherapy-Related Neurotoxicity.Axonal pathology in Krabbe's disease: The cytoskeleton as an emerging therapeutic target.Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy.Microtubule dynamics and the neurodegenerative triad of Alzheimer's disease: The hidden connection.Paclitaxel alters the evoked release of calcitonin gene-related peptide from rat sensory neurons in culture.Bortezomib alters microtubule polymerization and axonal transport in rat dorsal root ganglion neurons.Taxanes and platinum derivatives impair Schwann cells via distinct mechanismsThe early onset of peripheral neuropathy might be a robust predictor for time to treatment failure in patients with metastatic breast cancer receiving chemotherapy containing paclitaxel.Eribulin alone or in combination with the PLK1 inhibitor BI 6727 triggers intrinsic apoptosis in Ewing sarcoma cell lines.A Mechanistic Understanding of Axon Degeneration in Chemotherapy-Induced Peripheral Neuropathy.In vitro anticancer drug test: A new method emerges from the model of glioma stem cells.The cancer chemotherapeutic agent paclitaxel (Taxol) reduces hippocampal neurogenesis via down-regulation of vesicular zinc.Axonal Transport Impairment in Chemotherapy-Induced Peripheral Neuropathy
P2860
Q26799328-55E6C7E5-1333-40AB-AE55-912E47646CB5Q26824380-1B0C82A8-5134-44D8-9855-90EF5D90EC9EQ27010318-184F9FFF-5FD2-462B-841F-E967A28DD756Q27314983-A0E8F2CD-0E29-4CA8-96A7-AB9CA94AA8D7Q28071398-8482E772-B4E6-4B7E-8EE2-E26D221AFAD1Q28088354-636481BD-A5E8-4552-BFD2-7D04BBB95DD0Q30355359-33C80D73-620C-45A7-AE4A-FA857F2C2B0CQ33583474-400A197C-EC56-46A9-AF16-C704C32C0AFCQ33733061-1E9747B0-395B-4DBB-A77C-D76D7A2D4AE6Q33770927-2523AEB0-FF1F-4671-BD73-31A54F420780Q33857061-ACF4AA30-CC31-4358-BFD5-49A993E257F8Q34198719-B49A933C-D358-4BD1-A94D-A6CC53AD99FCQ35718193-80959CF9-70D6-4263-8A1D-620E6D5CB2CCQ36117686-3A49E86F-B218-4223-A2C3-49175F521023Q36226275-22D031E8-5360-4A19-AB0E-F52038CFC695Q36742259-9EC5C625-AF0E-44A0-8D88-2802B5D83935Q36884527-5DDC91B3-C902-4EB1-B183-41AE778B7919Q36963585-4E0C22FB-3B88-4AD7-B113-DA0D4B307622Q37534326-9F6B1038-403C-4D74-B29B-F056F568C6C1Q37574855-27523A5F-79F1-4853-8133-2F467DB8B291Q37659699-702DFDAF-5FE1-4409-A5A1-5360B0FEEFBEQ37662576-9EA79BAA-533F-41CE-B5CB-A607DE7085A4Q38160670-167320AA-55CF-4E51-99AD-D315D1EC5A4BQ38264622-6AA8FB51-344C-4987-8F11-D44B9A4299E2Q38658825-CF087B10-73BB-4860-AA92-8DCE8598DE86Q38722807-64496E19-4B52-4EBA-A02E-377A6D5E32E6Q38840985-349408A2-1455-43C1-9683-7CFAACB5EB96Q38904676-14EB4CD1-7E99-47E2-861C-15D06295BA41Q38957250-CB46E5BB-E190-49EE-A6EA-68B17304BB91Q39043749-91D70DF8-0F78-487D-BD5F-04BFFB91422DQ39165865-21F844A1-7530-43D5-B604-DBCA14547937Q39283600-E05B8662-FD1D-49A9-83F1-AF7AFBF7E795Q39350414-5FD55781-21FA-406B-B137-61B427BAEF5DQ41075945-25937043-9728-4E28-AEE0-369B4D47737CQ41227394-BD903C0D-748F-419D-BBBF-027442F59D3DQ41592750-6BCD4D61-9ECA-4C44-8179-FE401341F4A6Q41606031-5D3454EB-0D54-422F-AFA1-D5EAC545065DQ41681466-FCB98428-83ED-410B-993C-B980F1F62789Q41718205-9AF5FF7D-C4B6-446C-89AF-0CF74C0F6595Q42361415-35617474-3C3E-48D3-BAD4-F1AD795CDE62
P2860
Effects of eribulin, vincristine, paclitaxel and ixabepilone on fast axonal transport and kinesin-1 driven microtubule gliding: implications for chemotherapy-induced peripheral neuropathy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Effects of eribulin, vincristi ...... induced peripheral neuropathy.
@en
Effects of eribulin, vincristi ...... induced peripheral neuropathy.
@nl
type
label
Effects of eribulin, vincristi ...... induced peripheral neuropathy.
@en
Effects of eribulin, vincristi ...... induced peripheral neuropathy.
@nl
prefLabel
Effects of eribulin, vincristi ...... induced peripheral neuropathy.
@en
Effects of eribulin, vincristi ...... induced peripheral neuropathy.
@nl
P2093
P2860
P1433
P1476
Effects of eribulin, vincristi ...... induced peripheral neuropathy.
@en
P2093
Gerardo Morfini
Leslie Wilson
Mary Ann Jordan
Nichole E LaPointe
Scott T Brady
Stuart C Feinstein
P2860
P304
P356
10.1016/J.NEURO.2013.05.008
P577
2013-05-24T00:00:00Z